Living Kidney Donor Evaluation.
Age Factors
Clinical Decision-Making
Decision Support Techniques
Donor Selection
/ standards
Glomerular Filtration Rate
Health Status
Health Status Indicators
Humans
Kidney Transplantation
/ adverse effects
Living Donors
/ supply & distribution
Nephrectomy
/ adverse effects
Practice Guidelines as Topic
Predictive Value of Tests
Risk Assessment
Risk Factors
Treatment Outcome
Journal
Transplantation
ISSN: 1534-6080
Titre abrégé: Transplantation
Pays: United States
ID NLM: 0132144
Informations de publication
Date de publication:
12 2020
12 2020
Historique:
pubmed:
2
4
2020
medline:
9
2
2021
entrez:
2
4
2020
Statut:
ppublish
Résumé
Long-term safety of living kidney donation (LKD), especially for young donors, has become a real matter of concern in the transplant community and may contribute to creating resistance to LKD. In this context, the criteria that govern living donor donations must live up to very demanding standards as well as adjust to this novel reality. In the first part, we review the existing guidelines published after 2010 and critically examine their recommendations to see how they do not necessarily lead to consistent and universal practices in the choice of specific thresholds for a parameter used to accept or reject a living donor candidate. In the second part, we present the emergence of a new paradigm for LKD developed in the 2017 Kidney Disease: Improving Global Outcomes guidelines with the introduction of an integrative risk-based approach. Finally, we focus on predonation renal function evaluation, a criteria that remain central in the selection process, and discuss several issues surrounding the donor candidate's glomerular filtration rate assessment.
Identifiants
pubmed: 32229773
doi: 10.1097/TP.0000000000003242
pii: 00007890-202012000-00012
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
2487-2496Références
Reese PP, Boudville N, Garg AX. Living kidney donation: outcomes, ethics, and uncertainty. Lancet. 2015; 385:2003–2013
IRODaT Newsletter 2019. 2019. Available at http://www.irodat.org/img/database/pdf/IRODaT%20Newsletter%202019-March.pdf. Accessed September 9, 2019
2018 USRDS Annual Data Report. 201814. Available at https://www.usrds.org/2018/view/v1_00.aspx. Accessed September 9, 2019
Hart A, Smith JM, Skeans MA, et al. OPTN/SRTR 2017 Annual Data Report: Kidney. Am J Transplant. 2019; 19Suppl 219–123
Rapport de l’Agence de la Biomédecine 2018. Available at https://rams.agence-biomedecine.fr/sites/default/files/pdf/2019-09/RAMS%202018%20Rein.pdf. Accessed September 9, 2019
Yagisawa T, Mieno M, Ichimaru N, et al. Trends of kidney transplantation in Japan in 2018: data from the kidney transplant registry. Ren Replace Ther. 2019; 5
Pérez-Sáez MJ, Montero N, Redondo-Pachón D, et al. Strategies for an expanded use of kidneys from elderly donors. Transplantation. 2017; 101:727–745
Aubert O, Reese PP, Audry B, et al. Disparities in acceptance of deceased donor kidneys between the United States and France and estimated effects of increased US acceptance. [Epub ahead of print. August 26, 2019]. JAMA Intern Med. doi: 10.1001/jamainternmed.2019.2322
doi: 10.1001/jamainternmed.2019.2322
Mjøen G, Hallan S, Hartmann A, et al. Long-term risks for kidney donors. Kidney Int. 2014; 86:162–167
Muzaale AD, Massie AB, Wang MC, et al. Risk of end-stage renal disease following live kidney donation. JAMA. 2014; 311:579–586
Annual Scandiatransplant data report 2018. Available at http://www.scandiatransplant.org/resources/AnnualScandiatransplantdatareport2018.pdf. Accessed September 9, 2019
Andrews PA, Burnapp L. British transplantation society / renal association UK guidelines for living donor kidney transplantation 2018: summary of updated guidance. Transplantation. 2018; 102:e307
Lentine KL, Kasiske BL, Levey AS, et al. KDIGO clinical practice guideline on the evaluation and care of living kidney donors. Transplantation. 2017; 1018S Suppl 1S1–S109
Richardson R, Connelly M, Dipchand C, et al. Kidney paired donation protocol for participating donors 2014. Transplantation. 2015; 9910 suppl 1S1–S88
European Renal Best Practice Transplantation Guideline Development Group. ERBP Guideline on the Management and Evaluation of the Kidney Donor and Recipient. Nephrol Dial Transplant. 2013; 28Suppl 2ii1–ii71
Englum BR, Schechter MA, Irish WD, et al. Outcomes in kidney transplant recipients from older living donors. Transplantation. 2015; 99:309–315
Segev DL. Perioperative mortality and long-term survival following live kidney donation. JAMA. 2010; 303:959–966
Jacobs SC, Ramey JR, Sklar GN, et al. Laparoscopic kidney donation from patients older than 60 years. J Am Coll Surg. 2004; 198:892–897
Pei Y, Hwang YH, Conklin J, et al. Imaging-based diagnosis of autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 2015; 26:746–753
Mena-Gutierrez AM, Reeves-Daniel AM, Jay CL, et al. Practical considerations for APOL1 genotyping in the living kidney donor evaluation. Transplantation. 2020; 104:27–32
Ozdemir FN, Güz G, Sezer S, et al. Ambulatory blood pressure monitoring in potential renal transplant donors. Nephrol Dial Transplant. 2000; 15:1038–1040
Garg AX, Prasad GVR, Thiessen-Philbrook HR, et al. Cardiovascular disease and hypertension risk in living kidney donors: an analysis of health administrative data in Ontario, Canada. Transplantation. 2008; 86:399–406
Boudville N, Ramesh Prasad GV, Knoll G, et al. Meta-analysis: risk for hypertension in living kidney donors. Ann Intern Med. 2006; 145:185–196
Kasiske BL, Ma JZ, Louis TA, et al. Long-term effects of reduced renal mass in humans. Kidney Int. 1995; 48:814–819
Okumura K, Yamanaga S, Tanaka K, et al. Prediction model of compensation for contralateral kidney after living-donor donation. BMC Nephrol. 2019; 20:283
Textor SC. Blood pressure evaluation among older living kidney donors. J Am Soc Nephrol. 2003; 14:2159–2167
Harris MI. Undiagnosed NIDDM: clinical and public health issues. Diabetes Care. 1993; 16:642–652
Okamoto M, Suzuki T, Fujiki M, et al. The consequences for live kidney donors with preexisting glucose intolerance without diabetic complication: analysis at a single Japanese center. Transplantation. 2010; 89:1391–1395
Fabre J, Balant LP, Dayer PG, et al. The kidney in maturity onset diabetes mellitus: a clinical study of 510 patients. Kidney Int. 1982; 21:730–738
Anjum S, Muzaale AD, Massie AB, et al. Patterns of end-stage renal disease caused by diabetes, hypertension, and glomerulonephritis in live kidney donors. Am J Transplant. 2016; 16:3540–3547
Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2014; 384:766–781
Locke JE, Reed RD, Massie A, et al. Obesity increases the risk of end-stage renal disease among living kidney donors. Kidney Int. 2017; 91:699–703
Grams ME, Sang Y, Levey AS, et al. Kidney-failure risk projection for the living kidney-donor candidate. N Engl J Med. 2016; 374:411–421
Praga M, Hernández E, Herrero JC, et al. Influence of obesity on the appearance of proteinuria and renal insufficiency after unilateral nephrectomy. Kidney Int. 2000; 58:2111–2118
Halbesma N, Kuiken DS, Brantsma AH, et al. Macroalbuminuria is a better risk marker than low estimated GFR to identify individuals at risk for accelerated GFR loss in population screening. J Am Soc Nephrol. 2006; 17:2582–2590
Matsushita K, van der velde M, Astor BC, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010; 375:2073–2081
Jais JP. X-linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: a “European Community Alport Syndrome Concerted Action” study. J Am Soc Nephrol. 2003; 14:2603–2610
D’Amico G. Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Semin Nephrol. 2004; 24:179–196
Topham PS, Harper SJ, Furness PN, et al. Glomerular disease as a cause of isolated microscopic haematuria. Q J Med. 1994; 87:329–335
Vivante A, Afek A, Frenkel-Nir Y, et al. Persistent asymptomatic isolated microscopic hematuria in Israeli adolescents and young adults and risk for end-stage renal disease. JAMA. 2011; 306:729–736
Kido R, Shibagaki Y, Iwadoh K, et al. Persistent glomerular hematuria in living kidney donors confers a risk of progressive kidney disease in donors after heminephrectomy: risk for kidney disease in donors with hematuria. Am J Transplant. 2010; 10:1597–1604
Lorenz EC, Lieske JC, Vrtiska TJ, et al. Clinical characteristics of potential kidney donors with asymptomatic kidney stones. Nephrol Dial Transplant. 2011; 26:2695–2700
Strang AM, Lockhart ME, Amling CL, et al. Living renal donor allograft lithiasis: a review of stone related morbidity in donors and recipients. J Urol. 2008; 179:832–836
Xiao D, Craig JC, Chapman JR, et al. Donor cancer transmission in kidney transplantation: a systematic review: donor cancer transmission. Am J Transplant. 2013; 13:2645–2652
Nalesnik MA, Woodle ES, DiMaio JM, et al. Donor-transmitted malignancies in organ transplantation: assessment of clinical risk: donor malignancy transmission risk assessment. Am J Transplant. 2011; 11:1140–1147
Fonouni H, Mehrabi A, Golriz M, et al. Comparison of the laparoscopic versus open live donor nephrectomy: an overview of surgical complications and outcome. Langenbecks Arch Surg. 2014; 399:543–551
Yuan H, Liu L, Zheng S, et al. The safety and efficacy of laparoscopic donor nephrectomy for renal transplantation: an updated meta-analysis. Transplant Proc. 2013; 45:65–76
Fehrman-Ekholm I, Elinder CG, Stenbeck M, et al. Kidney donors live longer. Transplantation. 1997; 64:976–978
Ibrahim HN, Foley R, Tan L, et al. Long-term consequences of kidney donation. N Engl J Med. 2009; 360:459–469
Massie AB, Muzaale AD, Luo X, et al. Quantifying postdonation risk of ESRD in living kidney donors. J Am Soc Nephrol. 2017; 28:2749–2755
Ibrahim HN, Foley RN, Reule SA, et al. Renal function profile in white kidney donors: the first 4 decades. J Am Soc Nephrol. 2016; 27:2885–2893
Gaillard F, Fournier C, Legendre C. Lifetime ESKD risk stratification for living kidney donor studies. Am J Transplant. 2019; 19:2658–2659
Steiner RW. The risks of living kidney donation. N Engl J Med. 2016; 374:479–480
Matas Arthur J, Berglund Danielle M, Vock David M, et al. Causes and timing of end-stage renal disease after living kidney donation. Am J Transplant. 2018; 18:1140–1150
Steiner RW. Amending a historic paradigm for selecting living kidney donors. Am J Transplant. 2019; 19:2405–2406
Steiner RW. A very different paradigm for living kidney donor risk. Am J Transplant. 2017; 17:1701–1702
Hsu CY, McCulloch CE, Iribarren C, et al. Body mass index and risk for end-stage renal disease. Ann Intern Med. 2006; 144:21–28
Vivante A, Golan E, Tzur D, et al. Body mass index in 1.2 million adolescents and risk for end-stage renal disease. Arch Intern Med. 2012; 172:1644–1650
Steiner RW. “You can’t get there from here”: critical obstacles to current estimates of the ESRD risks of young living kidney donors. Am J Transplant. 2019; 19:32–36
Lentine KL, Schnitzler MA, Xiao H, et al. Racial variation in medical outcomes among living kidney donors. N Engl J Med. 2010; 363:724–732
Lenihan CR, Busque S, Derby G, et al. Longitudinal study of living kidney donor glomerular dynamics after nephrectomy. J Clin Invest. 2015; 125:1311–1318
Kasiske BL, Anderson-Haag T, Israni AK, et al. A prospective controlled study of living kidney donors: three-year follow-up. Am J Kidney Dis. 2015; 66:114–124
Garg AX, Muirhead N, Knoll G, et al. Proteinuria and reduced kidney function in living kidney donors: a systematic review, meta-analysis, and meta-regression. Kidney Int. 2006; 70:1801–1810
Merrill JP, Hartwell Harrison J, Murray J, et al. Successful homotransplantation of the kidney in an identical twin. Trans Am Clin Clim Assoc. 1956; 67:166–173
Oeconomos N, Hamburger J, Delinotte P, et al. Attempt at renal homograft (maternal kidney) after nephrectomy for traumatism of a lone kidney. Memoires Acad Chir Fr. 1953; 79:642–652
Gaillard F, Legendre C, White CA. GFR assessment of living kidney donors candidates. Transplantation. 2019; 103:1086–1093
Inker LA, Koraishy FM, Goyal N, et al. Assessment of glomerular filtration rate and end-stage kidney disease risk in living kidney donor candidates: a paradigm for evaluation, selection, and counseling. Adv Chronic Kidney Dis. 2018; 25:21–30
Sawinski D, Locke JE. AJKD Core Curriculum “Evaluation of Kidney Donors: Core Curriculum 2018.” Am J Kidney Dis. 2018; 71:737–747
Lam NN, Lentine KL, Garg AX. Renal and cardiac assessment of living kidney donor candidates. Nat Rev Nephrol. 2017; 13:420–428
Moore DR, Serur D, Rudow DL, et al. Living donor kidney transplantation: improving efficiencies in live kidney donor evaluation-recommendations from a consensus conference. Clin J Am Soc Nephrol. 2015; 10:1678–1686
Gaillard F, Courbebaisse M, Kamar N, et al. The age-calibrated measured glomerular filtration rate improves living kidney donation selection process. Kidney Int. 2018; 94:616–624
Chen JHC, Hughes P, Woodroffe C, et al. Pre- and postdonation kidney function in donors of kidney paired donation with unique criteria for donor glomerular filtration rate - a longitudinal cohort analysis. Transplant Int. 2019; 32:291–299
Matas AJ, Hays RE, Ibrahim HN. Long-term non-end-stage renal disease risks after living kidney donation. Am J Transplant. 2017; 17:893–900
Gaillard F, Courbebaisse M, Kamar N, et al. Impact of estimation versus direct measurement of predonation glomerular filtration rate on the eligibility of potential living kidney donors. Kidney Int. 2019; 95:896–904
Huang N, Foster MC, Lentine KL, et al. Estimated GFR for living kidney donor evaluation: eGFR and kidney donor evaluation. Am J Transplant. 2016; 16:171–180
Gaillard F, Flamant M, Lemoine S, et al. Estimated or measured GFR in living kidney donors work-up? Am J Transplant. 2016; 16:3024–3032
Soveri I, Berg UB, Bjork J, et al. Measuring GFR: a systematic review. Am J Kidney Dis. 2014; 64:411–424
Delanaye P, Cavalier E, Pottel H. Serum creatinine: not so simple! Nephron. 2017; 136:302–308
van Londen M, Wijninga AB, de Vries J, et al. Estimated glomerular filtration rate for longitudinal follow-up of living kidney donors. Nephrol Dial Transplant. 2018; 33:1054–1064
Steiner RW. ‘Normal for now’ or ‘at future risk’: a double standard for selecting young and older living kidney donors. Am J Transplant. 2010; 10:737–741
Ravani P, Fiocco M, Quinn RR, et al. Influence of mortality on estimating the risk of kidney failure in people with stage 4 chronic kidney disease. [Epub ahead of print. November 30, 2019]. J Am Soc Nephrol. doi: 10.1681/ASN.2019060640
doi: 10.1681/ASN.2019060640
Rodrigue JR, Schold JD, Mandelbrot DA, et al. Concern for lost income following donation deters some patients from talking to potential living donors. Prog Transplant. 2016; 26:292–298
Hays R, Rodrigue JR, Cohen D, et al. Financial neutrality for living organ donors: reasoning, rationale, definitions, and implementation strategies. Am J Transplant. 2016; 16:1973–1981
Bukabau JB, Yayo E, Gnionsahé A, et al. Performance of creatinine- or cystatin C-based equations to estimate glomerular filtration rate in sub-Saharan African populations. Kidney Int. 2019; 95:1181–1189
Pottel H, Delanaye P, Weekers L, et al. Age-dependent reference intervals for estimated and measured glomerular filtration rate. Clin Kidney J. 2017; 10:545–551
Kremers WK, Denic A, Lieske JC, et al. Distinguishing age-related from disease-related glomerulosclerosis on kidney biopsy: the aging kidney anatomy study. Nephrol Dial Transplant. 2015; 30:2034–2039
Denic A, Lieske JC, Chakkera HA, et al. The substantial loss of nephrons in healthy human kidneys with aging. J Am Soc Nephrol. 2017; 28:313–320
Denic A, Mathew J, Lerman LO, et al. Single-nephron glomerular filtration rate in healthy adults. N Engl J Med. 2017; 376:2349–2357
Denic A, Ricaurte L, Lopez CL, et al. Glomerular volume and glomerulosclerosis at different depths within the human kidney. J Am Soc Nephrol. 2019; 30:1471–1480
Denic A, Glassock RJ, Rule AD. Structural and functional changes with the aging kidney. Adv Chronic Kidney Dis. 2016; 23:19–28
Delanaye P, Glassock RJ, Pottel H, et al. An age-calibrated definition of chronic kidney disease: rationale and benefits. Clin Biochem Rev. 2016; 37:17–26
Ascher NL, Delmonico FL. Societal and professional obligation in the care of the living organ donor. Transplantation. 2019; 103:1080–1081